H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Summit Medical Group

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
Summit Medical Group
KYRank #FEIN 61-1300608

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPSummit Medical Group
Total filings80,813128
Certified %98.23%92.19%
Denied %1.09%1.56%
Withdrawn %0.61%3.13%
Cert-withdrawn %0.07%3.13%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePAKY

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Summit Medical Group

DOL case-status mix.

Outcome breakdown: Certified 92.2%, Cert-withdrawn 3.1%, Withdrawn 3.1%, Denied 1.6%
Outcome breakdown
OutcomeShare
Certified92.2%
Cert-withdrawn3.1%
Withdrawn3.1%
Denied1.6%
Certified92.2%
Cert-withdrawn3.1%
Withdrawn3.1%
Denied1.6%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
Summit Medical Group
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104
FY20110
FY20124
FY201317
FY201415
FY20156
FY201612
FY20176
FY201817
FY201920
FY20200
FY20210
FY20220
FY20230
FY202415
FY20256
FY20266

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — Summit Medical Group

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.